Literature for advisers
Access all the literature to help you and your clients in one handy and easy to use place. Use the tabs below.
Individual Protection
Fair value assessments
Critical Illness – fair value assessment
This document contains the outcome of AIG's Critical Illness fair value assessment, including the products in scope.
Income Protection – fair value assessment
This document contains the outcome of AIG's Income Protection fair value assessment, including the products in scope.
Guaranteed Whole of Life – fair value assessment
This document contains the outcome of AIG's Guaranteed Whole of Life fair value assessment, including the products in scope.
Life Insurance – fair value assessment
This document contains the outcome of AIG's Life Insurance fair value assessment, including the products in scope.
Income Protection – 2024 proposition update
This document contains the outcome of our Income Protection fair value assessment proposition update in 2024, including the products in scope.
Target market statements
For intermediaries
Product oversight and governance
This document provides information on AIG’s product oversight and governance framework. It also outlines how AIG meets the FCA’s product governance rules under policy statement PS21/5.
UWOL – target market statement
This document contains our individual protection target market statement for Underwritten Whole of Life. It's an overview of who is and isn’t right for the product and what type of adviser should sell it.
Term assurance, CI and IP – target market statements
This document contains our individual protection target market statements for AIG's Term Assurance, Critical Illness and Income Protection. It's an overview of who is and isn’t right for the products and what type of adviser should sell it.
Relevant Life and Business Protection – target market statements
This document contains our individual protection target market statements for AIG's Relevant Life and Business Protection. It's an overview of who is and isn’t right for the products and what type of adviser should sell it.
For partnerships
Product oversight and governance
This document provides information on AIG’s product oversight and governance framework. It also outlines how AIG meets the FCA’s product governance rules under policy statement PS21/5.
Natwest – target market statement
This document contains our Natwest Group target market statements – an overview of who is and isn’t right for a product and who should sell it.
Direct Line – target market statement
This document contains our Direct Line Group target market statements – an overview of who is and isn’t right for a product and who should sell it.
Neilson – target market statement
This document contains our Neilson Financial Services target market statements – an overview of who is and isn’t right for a product and who should sell it.
Skipton – target market statement
This document contains our Skipton Building Society target market statements – an overview of who is and isn’t right for a product and who should sell it.
Group Protection
Fair value assessments
Group Income Protection – fair value assessment
This document contains the outcome of AIG's Group Income Protection fair value assessment, including the products in scope.
Group Life – fair value assessment
This document contains the outcome of AIG's Group Life fair value assessment, including the products in scope.
Group Critical Illness – fair value assessment
This document contains the outcome of AIG's Group Critical Illness fair value assessment, including the products in scope.
Target market statements
Group target market statements
This document contains our Group Protection target market statements - an overview of who is and isn’t right for a product and what type of adviser should sell it.
Product oversight and governance
This document provides information on AIG’s product oversight and governance framework. It also outlines how AIG meets the FCA’s product governance rules under policy statement PS21/5.